Cargando…

Genes Associated With Prognosis After Surgery For Malignant Pleural Mesothelioma Promote Tumor Cell Survival In Vitro

BACKGROUND: Mesothelioma is an aggressive neoplasm with few effective treatments, one being cytoreductive surgery. We previously described a test, based on differential expression levels of four genes, to predict clinical outcome in prospectively consented mesothelioma patients after surgery. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gordon, Gavin J, Bueno, Raphael, Sugarbaker, David J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112160/ https://www.ncbi.nlm.nih.gov/pubmed/21569526 http://dx.doi.org/10.1186/1471-2407-11-169

Ejemplares similares

Differentially expressed alternatively spliced genes in Malignant Pleural Mesothelioma identified using massively parallel transcriptome sequencing
por: Dong, Lingsheng, et al.
Publicado: (2009)

Asbestos Burden Predicts Survival in Pleural Mesothelioma
por: Christensen, Brock C., et al.
Publicado: (2008)

Immune Microenvironment and Genetics in Malignant Pleural Mesothelioma
por: Wadowski, Benjamin, et al.
Publicado: (2021)

Cytomegalovirus infection in malignant pleural mesothelioma
por: Hunter-Schlichting, DeVon, et al.
Publicado: (2021)

Association of RERG Expression with Female Survival Advantage in Malignant Pleural Mesothelioma
por: De Rienzo, Assunta, et al.
Publicado: (2021)

Quantitative Clinical Staging for Patients With Malignant Pleural Mesothelioma
por: Gill, Ritu R, et al.
Publicado: (2017)

Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma
por: Lee, Hyun-Sung, et al.
Publicado: (2018)

Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma
por: Woodard, Gavitt A., et al.
Publicado: (2020)

Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma
por: Christensen, Brock C., et al.
Publicado: (2008)

Tumor volume is an independent predictor of survival in patients with malignant pleural mesothelioma
por: Kircheva, Diana Y, et al.
Publicado: (2015)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Tumor Microenvironment-Associated Immune-Related Genes for the Prognosis of Malignant Pleural Mesothelioma
por: Xu, Xiaoling, et al.
Publicado: (2020)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival
por: Quetel, Lisa, et al.
Publicado: (2020)

SMO mutations confer poor prognosis in malignant pleural mesothelioma
por: Signorelli, Diego, et al.
Publicado: (2020)

Pleural Fluid-to-Blood BNP Ratio May Contribute to Prognosis in Malignant Pleural Mesothelioma
por: Tsolaki, Vasiliki, et al.
Publicado: (2023)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma
por: Taioli, Emanuela, et al.
Publicado: (2015)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Malignant pleural mesothelioma in situ
por: Ando, Kohei, et al.
Publicado: (2022)

TGFα Promotes Chemoresistance of Malignant Pleural Mesothelioma
por: Staumont, Bernard, et al.
Publicado: (2020)

Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis
por: Kirschner, Michaela B, et al.
Publicado: (2015)

Survival Effect of Complete Multimodal Therapy in Malignant Pleural Mesothelioma
por: Sayan, Muhammet, et al.
Publicado: (2022)

Pleurectomy decortication is the preferred surgical procedure in pleural mesothelioma
por: Lapidot, Moshe, et al.
Publicado: (2023)

Improvement of Malignant Pleural Mesothelioma Prognosis: Early Diagnosis and Multimodality Treatment
por: Ban, Cheng-Jun, et al.
Publicado: (2017)

Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on
por: Ledda, Caterina, et al.
Publicado: (2018)

Level of mesothelin expression can indicate the prognosis of malignant pleural mesothelioma
por: Feng, Feifei, et al.
Publicado: (2020)

Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models
por: Barbone, Dario, et al.
Publicado: (2015)

KRAS signaling in malignant pleural mesothelioma
por: Marazioti, Antonia, et al.
Publicado: (2021)

Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014)

Thoracoscopy in Pleural Malignant Mesothelioma Diagnosis
por: Tassi, G. F., et al.
Publicado: (1997)

Imaging in staging of malignant pleural mesothelioma
por: Truong, Mylene T, et al.
Publicado: (2004)

Hedgehog Signaling in Malignant Pleural Mesothelioma
por: Felley-Bosco, Emanuela, et al.
Publicado: (2015)

Targeting YAP in malignant pleural mesothelioma
por: Zhang, Wen‐Qian, et al.
Publicado: (2017)

Multimodality treatment of malignant pleural mesothelioma
por: Berzenji, Lawek, et al.
Publicado: (2018)

Modern management of malignant pleural mesothelioma
por: Patel, Shivani C, et al.
Publicado: (2016)

Pleural tuberculosis mimicking malignant mesothelioma
por: Dawood, Wajahat, et al.
Publicado: (2019)

Immunotherapeutic Approaches in Malignant Pleural Mesothelioma
por: Terenziani, Rita, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qkhjolfs92dlp54hohaad0c254